The data regarding the potential benefits of direct stenting in the setting of angiographically apparent @entity715 -containing lesions are scarce. The aim of this study was to evaluate the impact of direct stenting on the angiographic results in the setting of @entity715 . We reviewed our institutional interventional database and identified 30 @entity1 who had undergone stenting in the setting of angiographically apparent @entity715 -containing lesions (33% unstable @entity951 , 67% acute @entity583 ). The majority of @entity1 had a baseline TIMI 2 and 3 flow (80%). Of the 6 @entity1 (20%) who had TIMI 0-1 flow at baseline, four of them achieved a TIMI 2 flow immediately after crossing the lesion with a 0.014 guidewire. Although the remaining 2 @entity1 had TIMI 1 flow, as distal opacification beyond the stenosis was obtained we successfully implanted the stents directly. All stents were successfully implanted without any crossing @entity177 or stent loss. There was no "no re-flow", with a final TIMI 3 flow rate in 93%. In 1 @entity1 with TIMI 2 flow after stenting, TIMI 3 flow was obtained after intracoronary @entity1855 . In 2 @entity1 (7%, TIMI 2 flow), a final TIMI 3 flow could not be achieved despite intracoronary @entity1242 and @entity1855 . There was no stent loss and imprecise stent placement. There were no in-hospital deaths, repeat interventions or coronary artery bypass graft surgeries. However, two @entity1 had undergone mitral valve replacement due to severe @entity339 . Eight @entity1 with recurrent @entity63 had control angiography; stents were found to be patent in all 8 @entity1 . Two @entity1 experienced recurrent @entity583 (6.6%). Direct stenting strategy in @entity715 -containing lesions seems to be a safe and feasible approach in avoiding no re-flow. We believe that benefits observed with direct stenting in this study should be compared to conventional stenting in the same setting with a randomized study.

Direct stenting in angiographically apparent XXXX -containing lesions.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity339 :: ('MESH:D008944', 'Disease') :: ['mitral regurgitation'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction'] @entity1242 :: ('MESH:D005996', 'Chemical') :: ['nitroglycerin'] @entity63 :: ('MESH:D007511', 'Disease') :: ['ischemia'] @entity1855 :: ('MESH:D014700', 'Chemical') :: ['verapamil'] @entity177 :: ('MESH:D051437', 'Disease') :: ['failure'] @entity951 :: ('MESH:D000787', 'Disease') :: ['angina pectoris'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombus']
@entity715 :: (MESH:D013927,Disease) :: ['thrombus']
